Emcure cuts Poviztra price to expand obesity therapy access

Addressing a growing public health challenge, Emcure Pharmaceuticals Ltd announced a price revision for Poviztra® across India. Effective April 3, 2026, the reduced price starts at ₹3,999 per month for four weekly doses. As the first Indian company to exclusively distribute and commercialise Poviztra®, Emcure aims to expand patient access to weight management therapy.